search
Back to results

A Pilot Study to Evaluate a Molecular Method for Plaque

Primary Purpose

Plaque, Gingivitis

Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
stannous fluoride toothpaste
cavity protection toothpaste
Sponsored by
Procter and Gamble
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional basic science trial for Plaque

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

In order to be included in the study, each subject must:

  • Provide written informed consent to participate in the study;
  • Be 18 years of age or older;
  • Agree not to participate in any other oral/dental product studies during the course of this study;
  • Agree to delay any elective dentistry (including dental prophylaxis) until the study has been completed;
  • Agree to maintain their current oral hygiene routine between the Screening and Baseline Visit and not to add/change their oral care products during this time;
  • Agree to refrain from any form of non-specified oral hygiene during the treatment periods (after the Baseline Visit), including but not limited to the use of products such as floss or whitening products;
  • Agree to return for all scheduled visits and follow study procedures;
  • Must have at least 16 natural teeth;
  • Be in good general health, as determined by the Investigator/designee based on a review of the health history/update for participation in the study;
  • Agree to refrain from all oral hygiene for at least 12 hours prior to each visit;
  • Agree to refrain from eating, chewing gum, drinking and using tobacco for 4 hours prior to each visit;
  • Have at least 20 bleeding sites (sites with a score of 1 or 2 on the GBI index);
  • Have minimum 3 sampling sites with bleeding and pocket depth ≥3mm but not deeper than 4mm;
  • Have minimum 3 sampling sites without bleeding and with pocket depth ≤2mm.

Exclusion Criteria:

Subjects are excluded from study participation where there is evidence of:

  • Have had a dental prophylaxis within 2 weeks of plaque sampling visits;
  • Have taken antibiotics or used anti-gingivitis / anti-bacterial oral care products such as chlorhexidine or Listerine within 2 weeks of plaque sampling visits;
  • Have rampant caries, open or untreated caries, or advanced periodontitis requiring prompt treatment;
  • Need an antibiotic prophylaxis prior to dental visits;
  • A history of hypersensitivity to oral care products containing stannous fluoride;
  • A history of hypersensitivity to dyes (from products containing food dyes);
  • Present with any disease or condition(s) that could be expected to interfere with examination procedures or the subject's safe completion of the study; or
  • Are pregnant (Self-reported) or lactating.

Sites / Locations

  • Salus Research

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Sham Comparator

Arm Label

stannous fluoride toothpaste

cavity protection toothpaste

Arm Description

brush twice a day for 8 weeks

brush twice a day for 8 weeks

Outcomes

Primary Outcome Measures

plaque scores
plaque scores

Secondary Outcome Measures

gingivitis score
gingivitis score

Full Information

First Posted
October 9, 2015
Last Updated
October 4, 2017
Sponsor
Procter and Gamble
search

1. Study Identification

Unique Protocol Identification Number
NCT02574221
Brief Title
A Pilot Study to Evaluate a Molecular Method for Plaque
Official Title
A Pilot Study to Evaluate the Sensitivity of a Novel Molecular Method for Plaque Toxicity
Study Type
Interventional

2. Study Status

Record Verification Date
October 2017
Overall Recruitment Status
Completed
Study Start Date
August 2015 (undefined)
Primary Completion Date
October 2015 (Actual)
Study Completion Date
October 2015 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Procter and Gamble

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No

5. Study Description

Brief Summary
This study is to evaluate the sensitivity of the molecular method and its ability to split a stannous fluoride toothpaste versus a negative control.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Plaque, Gingivitis

7. Study Design

Primary Purpose
Basic Science
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantInvestigator
Allocation
Randomized
Enrollment
60 (Actual)

8. Arms, Groups, and Interventions

Arm Title
stannous fluoride toothpaste
Arm Type
Experimental
Arm Description
brush twice a day for 8 weeks
Arm Title
cavity protection toothpaste
Arm Type
Sham Comparator
Arm Description
brush twice a day for 8 weeks
Intervention Type
Drug
Intervention Name(s)
stannous fluoride toothpaste
Intervention Description
0.454% stannous fluoride toothpaste
Intervention Type
Drug
Intervention Name(s)
cavity protection toothpaste
Intervention Description
0.243% sodium fluoride toothpaste
Primary Outcome Measure Information:
Title
plaque scores
Time Frame
baseline
Title
plaque scores
Time Frame
week 8
Secondary Outcome Measure Information:
Title
gingivitis score
Time Frame
baseline
Title
gingivitis score
Time Frame
week 8

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: In order to be included in the study, each subject must: Provide written informed consent to participate in the study; Be 18 years of age or older; Agree not to participate in any other oral/dental product studies during the course of this study; Agree to delay any elective dentistry (including dental prophylaxis) until the study has been completed; Agree to maintain their current oral hygiene routine between the Screening and Baseline Visit and not to add/change their oral care products during this time; Agree to refrain from any form of non-specified oral hygiene during the treatment periods (after the Baseline Visit), including but not limited to the use of products such as floss or whitening products; Agree to return for all scheduled visits and follow study procedures; Must have at least 16 natural teeth; Be in good general health, as determined by the Investigator/designee based on a review of the health history/update for participation in the study; Agree to refrain from all oral hygiene for at least 12 hours prior to each visit; Agree to refrain from eating, chewing gum, drinking and using tobacco for 4 hours prior to each visit; Have at least 20 bleeding sites (sites with a score of 1 or 2 on the GBI index); Have minimum 3 sampling sites with bleeding and pocket depth ≥3mm but not deeper than 4mm; Have minimum 3 sampling sites without bleeding and with pocket depth ≤2mm. Exclusion Criteria: Subjects are excluded from study participation where there is evidence of: Have had a dental prophylaxis within 2 weeks of plaque sampling visits; Have taken antibiotics or used anti-gingivitis / anti-bacterial oral care products such as chlorhexidine or Listerine within 2 weeks of plaque sampling visits; Have rampant caries, open or untreated caries, or advanced periodontitis requiring prompt treatment; Need an antibiotic prophylaxis prior to dental visits; A history of hypersensitivity to oral care products containing stannous fluoride; A history of hypersensitivity to dyes (from products containing food dyes); Present with any disease or condition(s) that could be expected to interfere with examination procedures or the subject's safe completion of the study; or Are pregnant (Self-reported) or lactating.
Facility Information:
Facility Name
Salus Research
City
Fort Wayne
State/Province
Indiana
ZIP/Postal Code
46825
Country
United States

12. IPD Sharing Statement

Learn more about this trial

A Pilot Study to Evaluate a Molecular Method for Plaque

We'll reach out to this number within 24 hrs